{
  "ticker": "EW",
  "last_updated": "2025-04-15T16:12:15.965878",
  "retention_years": 3,
  "count": 740,
  "transactions": [
    {
      "id": 181727,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-01-12",
      "transaction_shares": "10000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "49502.6931"
    },
    {
      "id": 181805,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 181671,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-12-29",
      "transaction_shares": "14510.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33758.0000"
    },
    {
      "id": 181763,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-12-15",
      "transaction_shares": "7000.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "30950.0000"
    },
    {
      "id": 181743,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-12-13",
      "transaction_shares": "8000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "47502.6931"
    },
    {
      "id": 181752,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-12-13",
      "transaction_shares": "8658.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "222451.7137"
    },
    {
      "id": 181768,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-12-13",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 181794,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-12-06",
      "transaction_shares": "3500.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "27450.0000"
    },
    {
      "id": 181736,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-11-13",
      "transaction_shares": "8660.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "222453.7137"
    },
    {
      "id": 181804,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-11-13",
      "transaction_shares": "6000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "45502.6931"
    },
    {
      "id": 181741,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-11-03",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 181694,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-10-31",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 131815,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-10-13",
      "transaction_shares": "8660.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "222453.7137"
    },
    {
      "id": 131926,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-10-13",
      "transaction_shares": "5000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "44502.6931"
    },
    {
      "id": 181679,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-10-13",
      "transaction_shares": "8660.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "222453.7137"
    },
    {
      "id": 181799,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-10-13",
      "transaction_shares": "5000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "44502.6931"
    },
    {
      "id": 131868,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-10-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "39813.5710"
    },
    {
      "id": 181734,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-10-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "39813.5710"
    },
    {
      "id": 131909,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-10-03",
      "transaction_shares": "8500.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "32450.0000"
    },
    {
      "id": 181781,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-10-03",
      "transaction_shares": "8500.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "32450.0000"
    },
    {
      "id": 131811,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-10-02",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 181675,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-10-02",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 131791,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-09-29",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 181654,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-09-29",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 131810,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-09-14",
      "transaction_shares": "4500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "44002.6931"
    },
    {
      "id": 131889,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2023-09-14",
      "transaction_shares": "7262.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "7262.0000"
    },
    {
      "id": 131949,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-09-14",
      "transaction_shares": "8660.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "222453.7137"
    },
    {
      "id": 181674,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-09-14",
      "transaction_shares": "4500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "44002.6931"
    },
    {
      "id": 181759,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2023-09-14",
      "transaction_shares": "7262.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "7262.0000"
    },
    {
      "id": 181824,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-09-14",
      "transaction_shares": "8660.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "222453.7137"
    },
    {
      "id": 131916,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-09-08",
      "transaction_shares": "5000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "39813.5710"
    },
    {
      "id": 181788,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-09-08",
      "transaction_shares": "5000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "39813.5710"
    },
    {
      "id": 131859,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-09-06",
      "transaction_shares": "8500.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "32450.0000"
    },
    {
      "id": 181724,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-09-06",
      "transaction_shares": "8500.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "32450.0000"
    },
    {
      "id": 131866,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-09-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 181732,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-09-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 131924,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-08-31",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 131931,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-08-31",
      "transaction_shares": "49766.0000",
      "transaction_price": "0.0000",
      "transaction_type": "G",
      "shares_after_transaction": "4485.8200"
    },
    {
      "id": 181797,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-08-31",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 181806,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-08-31",
      "transaction_shares": "49766.0000",
      "transaction_price": "0.0000",
      "transaction_type": "G",
      "shares_after_transaction": "4485.8200"
    },
    {
      "id": 131805,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-08-29",
      "transaction_shares": "1500.0000",
      "transaction_price": "76.6936",
      "transaction_type": "S",
      "shares_after_transaction": "23950.0000"
    },
    {
      "id": 181668,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-08-29",
      "transaction_shares": "1500.0000",
      "transaction_price": "76.6936",
      "transaction_type": "S",
      "shares_after_transaction": "23950.0000"
    },
    {
      "id": 131840,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-08-14",
      "transaction_shares": "4500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "44002.6931"
    },
    {
      "id": 131847,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-08-14",
      "transaction_shares": "6421.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "220214.7137"
    },
    {
      "id": 181705,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-08-14",
      "transaction_shares": "4500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "44002.6931"
    },
    {
      "id": 181712,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-08-14",
      "transaction_shares": "6421.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "220214.7137"
    },
    {
      "id": 131849,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2023-08-10",
      "transaction_shares": "3303.0000",
      "transaction_price": "78.8703",
      "transaction_type": "S",
      "shares_after_transaction": "26980.0000"
    },
    {
      "id": 181714,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2023-08-10",
      "transaction_shares": "3303.0000",
      "transaction_price": "78.8703",
      "transaction_type": "S",
      "shares_after_transaction": "26980.0000"
    },
    {
      "id": 131943,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-08-09",
      "transaction_shares": "5000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "39813.5710"
    },
    {
      "id": 181818,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-08-09",
      "transaction_shares": "5000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "39813.5710"
    },
    {
      "id": 131885,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-08-07",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "83601.8200"
    },
    {
      "id": 181755,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-08-07",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "83601.8200"
    },
    {
      "id": 131818,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-07-31",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 131856,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2023-07-31",
      "transaction_shares": "2558.6207",
      "transaction_price": "83.5389",
      "transaction_type": "I",
      "shares_after_transaction": "47111.4942"
    },
    {
      "id": 181682,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-07-31",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 181721,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2023-07-31",
      "transaction_shares": "2558.6207",
      "transaction_price": "83.5389",
      "transaction_type": "I",
      "shares_after_transaction": "47111.4942"
    },
    {
      "id": 88411,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-07-14",
      "transaction_shares": "3500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "43002.6931"
    },
    {
      "id": 88459,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-07-14",
      "transaction_shares": "8660.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "222453.7137"
    },
    {
      "id": 131890,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-07-14",
      "transaction_shares": "3500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "43002.6931"
    },
    {
      "id": 131944,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-07-14",
      "transaction_shares": "8660.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "222453.7137"
    },
    {
      "id": 181760,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-07-14",
      "transaction_shares": "3500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "43002.6931"
    },
    {
      "id": 181819,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-07-14",
      "transaction_shares": "8660.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "222453.7137"
    },
    {
      "id": 88383,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-07-07",
      "transaction_shares": "252.0000",
      "transaction_price": "90.4600",
      "transaction_type": "F",
      "shares_after_transaction": "34813.5710"
    },
    {
      "id": 88403,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-07-07",
      "transaction_shares": "81.0000",
      "transaction_price": "90.4600",
      "transaction_type": "F",
      "shares_after_transaction": "173583.7785"
    },
    {
      "id": 131857,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-07-07",
      "transaction_shares": "252.0000",
      "transaction_price": "90.4600",
      "transaction_type": "F",
      "shares_after_transaction": "34813.5710"
    },
    {
      "id": 131880,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-07-07",
      "transaction_shares": "81.0000",
      "transaction_price": "90.4600",
      "transaction_type": "F",
      "shares_after_transaction": "173583.7785"
    },
    {
      "id": 181722,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-07-07",
      "transaction_shares": "252.0000",
      "transaction_price": "90.4600",
      "transaction_type": "F",
      "shares_after_transaction": "34813.5710"
    },
    {
      "id": 181749,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-07-07",
      "transaction_shares": "81.0000",
      "transaction_price": "90.4600",
      "transaction_type": "F",
      "shares_after_transaction": "173583.7785"
    },
    {
      "id": 88442,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-07-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "83601.8200"
    },
    {
      "id": 131923,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-07-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "83601.8200"
    },
    {
      "id": 181796,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-07-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "83601.8200"
    },
    {
      "id": 88349,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-06-30",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 131819,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-06-30",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 181683,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-06-30",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 88394,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-06-14",
      "transaction_shares": "8660.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "222453.7137"
    },
    {
      "id": 88417,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-06-14",
      "transaction_shares": "3500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "43002.6931"
    },
    {
      "id": 131871,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-06-14",
      "transaction_shares": "8660.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "222453.7137"
    },
    {
      "id": 131896,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-06-14",
      "transaction_shares": "3500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "43002.6931"
    },
    {
      "id": 181738,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-06-14",
      "transaction_shares": "8660.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "222453.7137"
    },
    {
      "id": 181767,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-06-14",
      "transaction_shares": "3500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "43002.6931"
    },
    {
      "id": 88423,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-06-13",
      "transaction_shares": "5000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "40055.7795"
    },
    {
      "id": 131902,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-06-13",
      "transaction_shares": "5000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "40055.7795"
    },
    {
      "id": 181774,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-06-13",
      "transaction_shares": "5000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "40055.7795"
    },
    {
      "id": 88329,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-06-01",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "115559.8200"
    },
    {
      "id": 131794,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-06-01",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "115559.8200"
    },
    {
      "id": 181657,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-06-01",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "115559.8200"
    },
    {
      "id": 88437,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-05-24",
      "transaction_shares": "6421.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "220214.7137"
    },
    {
      "id": 131918,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-05-24",
      "transaction_shares": "6421.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "220214.7137"
    },
    {
      "id": 181790,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-05-24",
      "transaction_shares": "6421.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "220214.7137"
    },
    {
      "id": 88449,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-05-17",
      "transaction_shares": "8496.0000",
      "transaction_price": "0.0000",
      "transaction_type": "G",
      "shares_after_transaction": "19248.0000"
    },
    {
      "id": 131933,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-05-17",
      "transaction_shares": "8496.0000",
      "transaction_price": "0.0000",
      "transaction_type": "G",
      "shares_after_transaction": "19248.0000"
    },
    {
      "id": 181808,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-05-17",
      "transaction_shares": "8496.0000",
      "transaction_price": "0.0000",
      "transaction_type": "G",
      "shares_after_transaction": "19248.0000"
    },
    {
      "id": 88328,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "7718.0000"
    },
    {
      "id": 88339,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "68914.0000"
    },
    {
      "id": 88340,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Marsh Martha H.",
      "reporting_owner_cik": "0001500281",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31880.0000"
    },
    {
      "id": 88360,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "5103.0000"
    },
    {
      "id": 88378,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "4485.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "86209.8200"
    },
    {
      "id": 88398,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "55420.0000"
    },
    {
      "id": 88445,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2803.0000"
    },
    {
      "id": 88451,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "30283.0000"
    },
    {
      "id": 131793,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "7718.0000"
    },
    {
      "id": 131804,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "68914.0000"
    },
    {
      "id": 131806,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Marsh Martha H.",
      "reporting_owner_cik": "0001500281",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31880.0000"
    },
    {
      "id": 131830,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "5103.0000"
    },
    {
      "id": 131851,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "4485.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "86209.8200"
    },
    {
      "id": 131875,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "55420.0000"
    },
    {
      "id": 131928,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2803.0000"
    },
    {
      "id": 131935,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "30283.0000"
    },
    {
      "id": 181656,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "7718.0000"
    },
    {
      "id": 181667,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "68914.0000"
    },
    {
      "id": 181669,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Marsh Martha H.",
      "reporting_owner_cik": "0001500281",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31880.0000"
    },
    {
      "id": 181695,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "5103.0000"
    },
    {
      "id": 181716,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "4485.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "86209.8200"
    },
    {
      "id": 181744,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "55420.0000"
    },
    {
      "id": 181801,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2803.0000"
    },
    {
      "id": 181810,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "30283.0000"
    },
    {
      "id": 88347,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "President",
      "transaction_date": "2023-05-11",
      "transaction_shares": "22525.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "44552.8735"
    },
    {
      "id": 88377,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-05-11",
      "transaction_shares": "6475.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "25450.0000"
    },
    {
      "id": 88385,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-05-11",
      "transaction_shares": "6525.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "35055.7795"
    },
    {
      "id": 88399,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-05-11",
      "transaction_shares": "1575.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "173664.7785"
    },
    {
      "id": 88407,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-05-11",
      "transaction_shares": "9450.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "27744.0000"
    },
    {
      "id": 88420,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-05-11",
      "transaction_shares": "7775.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "213793.7137"
    },
    {
      "id": 88429,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2023-05-11",
      "transaction_shares": "1800.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "13035.7904"
    },
    {
      "id": 88462,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-05-11",
      "transaction_shares": "6425.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "39502.6931"
    },
    {
      "id": 131816,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "President",
      "transaction_date": "2023-05-11",
      "transaction_shares": "22525.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "44552.8735"
    },
    {
      "id": 131850,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-05-11",
      "transaction_shares": "6475.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "25450.0000"
    },
    {
      "id": 131860,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-05-11",
      "transaction_shares": "6525.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "35055.7795"
    },
    {
      "id": 131876,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-05-11",
      "transaction_shares": "1575.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "173664.7785"
    },
    {
      "id": 131884,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-05-11",
      "transaction_shares": "9450.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "27744.0000"
    },
    {
      "id": 131899,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-05-11",
      "transaction_shares": "7775.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "213793.7137"
    },
    {
      "id": 131908,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2023-05-11",
      "transaction_shares": "1800.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "13035.7904"
    },
    {
      "id": 131947,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-05-11",
      "transaction_shares": "6425.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "39502.6931"
    },
    {
      "id": 181680,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "President",
      "transaction_date": "2023-05-11",
      "transaction_shares": "22525.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "44552.8735"
    },
    {
      "id": 181715,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-05-11",
      "transaction_shares": "6475.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "25450.0000"
    },
    {
      "id": 181725,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-05-11",
      "transaction_shares": "6525.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "35055.7795"
    },
    {
      "id": 181745,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-05-11",
      "transaction_shares": "1575.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "173664.7785"
    },
    {
      "id": 181754,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-05-11",
      "transaction_shares": "9450.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "27744.0000"
    },
    {
      "id": 181771,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-05-11",
      "transaction_shares": "7775.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "213793.7137"
    },
    {
      "id": 181780,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2023-05-11",
      "transaction_shares": "1800.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "13035.7904"
    },
    {
      "id": 181822,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-05-11",
      "transaction_shares": "6425.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "39502.6931"
    },
    {
      "id": 88331,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-05-10",
      "transaction_shares": "2500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "35577.6931"
    },
    {
      "id": 88335,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-05-10",
      "transaction_shares": "80700.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "98994.0000"
    },
    {
      "id": 131796,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-05-10",
      "transaction_shares": "2500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "35577.6931"
    },
    {
      "id": 131800,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-05-10",
      "transaction_shares": "80700.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "98994.0000"
    },
    {
      "id": 181659,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-05-10",
      "transaction_shares": "2500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "35577.6931"
    },
    {
      "id": 181663,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-05-10",
      "transaction_shares": "80700.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "98994.0000"
    },
    {
      "id": 88338,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-05-07",
      "transaction_shares": "3413.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "21764.0000"
    },
    {
      "id": 88343,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-05-07",
      "transaction_shares": "20777.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "81724.8200"
    },
    {
      "id": 88354,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "President",
      "transaction_date": "2023-05-07",
      "transaction_shares": "5003.0000",
      "transaction_price": "0.0000",
      "transaction_type": "M",
      "shares_after_transaction": "25783.8735"
    },
    {
      "id": 88356,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2023-05-07",
      "transaction_shares": "134.0000",
      "transaction_price": "88.7400",
      "transaction_type": "F",
      "shares_after_transaction": "11396.7904"
    },
    {
      "id": 88358,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-05-07",
      "transaction_shares": "4708.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "32060.7795"
    },
    {
      "id": 88362,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP & Grp President TAVR & SSH",
      "transaction_date": "2023-05-07",
      "transaction_shares": "5415.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "210365.7137"
    },
    {
      "id": 88381,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-05-07",
      "transaction_shares": "3355.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "172417.7785"
    },
    {
      "id": 88461,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-05-07",
      "transaction_shares": "6062.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "22972.0000"
    },
    {
      "id": 131803,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-05-07",
      "transaction_shares": "3413.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "21764.0000"
    },
    {
      "id": 131809,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-05-07",
      "transaction_shares": "20777.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "81724.8200"
    },
    {
      "id": 131824,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "President",
      "transaction_date": "2023-05-07",
      "transaction_shares": "5003.0000",
      "transaction_price": "0.0000",
      "transaction_type": "M",
      "shares_after_transaction": "25783.8735"
    },
    {
      "id": 131826,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2023-05-07",
      "transaction_shares": "134.0000",
      "transaction_price": "88.7400",
      "transaction_type": "F",
      "shares_after_transaction": "11396.7904"
    },
    {
      "id": 131828,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-05-07",
      "transaction_shares": "4708.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "32060.7795"
    },
    {
      "id": 131832,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP & Grp President TAVR & SSH",
      "transaction_date": "2023-05-07",
      "transaction_shares": "5415.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "210365.7137"
    },
    {
      "id": 131854,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-05-07",
      "transaction_shares": "3355.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "172417.7785"
    },
    {
      "id": 131946,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-05-07",
      "transaction_shares": "6062.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "22972.0000"
    },
    {
      "id": 181666,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-05-07",
      "transaction_shares": "3413.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "21764.0000"
    },
    {
      "id": 181673,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-05-07",
      "transaction_shares": "20777.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "81724.8200"
    },
    {
      "id": 181688,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "President",
      "transaction_date": "2023-05-07",
      "transaction_shares": "5003.0000",
      "transaction_price": "0.0000",
      "transaction_type": "M",
      "shares_after_transaction": "25783.8735"
    },
    {
      "id": 181690,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2023-05-07",
      "transaction_shares": "134.0000",
      "transaction_price": "88.7400",
      "transaction_type": "F",
      "shares_after_transaction": "11396.7904"
    },
    {
      "id": 181692,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-05-07",
      "transaction_shares": "4708.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "32060.7795"
    },
    {
      "id": 181697,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP & Grp President TAVR & SSH",
      "transaction_date": "2023-05-07",
      "transaction_shares": "5415.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "210365.7137"
    },
    {
      "id": 181719,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-05-07",
      "transaction_shares": "3355.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "172417.7785"
    },
    {
      "id": 181821,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-05-07",
      "transaction_shares": "6062.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "22972.0000"
    },
    {
      "id": 88346,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-05-05",
      "transaction_shares": "5635.0000",
      "transaction_price": "88.6250",
      "transaction_type": "S",
      "shares_after_transaction": "56224.6931"
    },
    {
      "id": 131814,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-05-05",
      "transaction_shares": "5635.0000",
      "transaction_price": "88.6250",
      "transaction_type": "S",
      "shares_after_transaction": "56224.6931"
    },
    {
      "id": 181678,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-05-05",
      "transaction_shares": "5635.0000",
      "transaction_price": "88.6250",
      "transaction_type": "S",
      "shares_after_transaction": "56224.6931"
    },
    {
      "id": 88337,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "President",
      "transaction_date": "2023-05-03",
      "transaction_shares": "359.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "21150.8735"
    },
    {
      "id": 88345,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2023-05-03",
      "transaction_shares": "103.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "11646.7904"
    },
    {
      "id": 88357,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-05-03",
      "transaction_shares": "433.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "17351.0000"
    },
    {
      "id": 88366,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP & Grp President TAVR & SSH",
      "transaction_date": "2023-05-03",
      "transaction_shares": "383.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "205346.7137"
    },
    {
      "id": 88391,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-05-03",
      "transaction_shares": "37.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "169100.7785"
    },
    {
      "id": 88416,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-05-03",
      "transaction_shares": "468.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "62355.6931"
    },
    {
      "id": 88425,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-05-03",
      "transaction_shares": "281.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "18630.0000"
    },
    {
      "id": 88432,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-05-03",
      "transaction_shares": "327.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "27696.7795"
    },
    {
      "id": 131802,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "President",
      "transaction_date": "2023-05-03",
      "transaction_shares": "359.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "21150.8735"
    },
    {
      "id": 131813,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2023-05-03",
      "transaction_shares": "103.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "11646.7904"
    },
    {
      "id": 131827,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-05-03",
      "transaction_shares": "433.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "17351.0000"
    },
    {
      "id": 131836,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP & Grp President TAVR & SSH",
      "transaction_date": "2023-05-03",
      "transaction_shares": "383.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "205346.7137"
    },
    {
      "id": 131867,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-05-03",
      "transaction_shares": "37.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "169100.7785"
    },
    {
      "id": 131895,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-05-03",
      "transaction_shares": "468.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "62355.6931"
    },
    {
      "id": 131904,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-05-03",
      "transaction_shares": "281.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "18630.0000"
    },
    {
      "id": 131912,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-05-03",
      "transaction_shares": "327.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "27696.7795"
    },
    {
      "id": 181665,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "President",
      "transaction_date": "2023-05-03",
      "transaction_shares": "359.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "21150.8735"
    },
    {
      "id": 181677,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2023-05-03",
      "transaction_shares": "103.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "11646.7904"
    },
    {
      "id": 181691,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-05-03",
      "transaction_shares": "433.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "17351.0000"
    },
    {
      "id": 181701,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP & Grp President TAVR & SSH",
      "transaction_date": "2023-05-03",
      "transaction_shares": "383.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "205346.7137"
    },
    {
      "id": 181733,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-05-03",
      "transaction_shares": "37.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "169100.7785"
    },
    {
      "id": 181766,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-05-03",
      "transaction_shares": "468.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "62355.6931"
    },
    {
      "id": 181776,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-05-03",
      "transaction_shares": "281.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "18630.0000"
    },
    {
      "id": 181784,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-05-03",
      "transaction_shares": "327.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "27696.7795"
    },
    {
      "id": 88330,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2023-04-28",
      "transaction_shares": "12270.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "24019.7904"
    },
    {
      "id": 131795,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2023-04-28",
      "transaction_shares": "12270.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "24019.7904"
    },
    {
      "id": 181658,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2023-04-28",
      "transaction_shares": "12270.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "24019.7904"
    },
    {
      "id": 52583,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-04-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "90322.8200"
    },
    {
      "id": 88434,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-04-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "90322.8200"
    },
    {
      "id": 131914,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-04-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "90322.8200"
    },
    {
      "id": 181786,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-04-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "90322.8200"
    },
    {
      "id": 52526,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-04-06",
      "transaction_shares": "6640.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "175777.7785"
    },
    {
      "id": 52547,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-04-06",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69548.6931"
    },
    {
      "id": 88351,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-04-06",
      "transaction_shares": "6640.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "175777.7785"
    },
    {
      "id": 88382,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-04-06",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69548.6931"
    },
    {
      "id": 131821,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-04-06",
      "transaction_shares": "6640.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "175777.7785"
    },
    {
      "id": 131855,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-04-06",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69548.6931"
    },
    {
      "id": 181685,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-04-06",
      "transaction_shares": "6640.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "175777.7785"
    },
    {
      "id": 181720,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-04-06",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69548.6931"
    },
    {
      "id": 52573,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-03-15",
      "transaction_shares": "4435.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23346.0000"
    },
    {
      "id": 88419,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-03-15",
      "transaction_shares": "4435.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23346.0000"
    },
    {
      "id": 131898,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-03-15",
      "transaction_shares": "4435.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23346.0000"
    },
    {
      "id": 181770,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-03-15",
      "transaction_shares": "4435.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23346.0000"
    },
    {
      "id": 52531,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-03-08",
      "transaction_shares": "6640.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "175514.8696"
    },
    {
      "id": 52571,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-03-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 88361,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-03-08",
      "transaction_shares": "6640.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "175514.8696"
    },
    {
      "id": 88415,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-03-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 131831,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-03-08",
      "transaction_shares": "6640.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "175514.8696"
    },
    {
      "id": 131894,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-03-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 181696,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-03-08",
      "transaction_shares": "6640.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "175514.8696"
    },
    {
      "id": 181765,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-03-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 52535,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-02-21",
      "transaction_shares": "335.0000",
      "transaction_price": "78.5100",
      "transaction_type": "F",
      "shares_after_transaction": "17784.0000"
    },
    {
      "id": 88367,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-02-21",
      "transaction_shares": "335.0000",
      "transaction_price": "78.5100",
      "transaction_type": "F",
      "shares_after_transaction": "17784.0000"
    },
    {
      "id": 131837,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-02-21",
      "transaction_shares": "335.0000",
      "transaction_price": "78.5100",
      "transaction_type": "F",
      "shares_after_transaction": "17784.0000"
    },
    {
      "id": 181702,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-02-21",
      "transaction_shares": "335.0000",
      "transaction_price": "78.5100",
      "transaction_type": "F",
      "shares_after_transaction": "17784.0000"
    },
    {
      "id": 52551,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP & Grp President TAVR & SSH",
      "transaction_date": "2023-02-16",
      "transaction_shares": "3235.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "205466.8049"
    },
    {
      "id": 52562,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-02-16",
      "transaction_shares": "1941.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "18119.0000"
    },
    {
      "id": 52602,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-16",
      "transaction_shares": "9671.0000",
      "transaction_price": "35.6767",
      "transaction_type": "M",
      "shares_after_transaction": "37151.0000"
    },
    {
      "id": 88388,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP & Grp President TAVR & SSH",
      "transaction_date": "2023-02-16",
      "transaction_shares": "3235.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "205466.8049"
    },
    {
      "id": 88404,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-02-16",
      "transaction_shares": "1941.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "18119.0000"
    },
    {
      "id": 88458,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-16",
      "transaction_shares": "9671.0000",
      "transaction_price": "35.6767",
      "transaction_type": "M",
      "shares_after_transaction": "37151.0000"
    },
    {
      "id": 131863,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP & Grp President TAVR & SSH",
      "transaction_date": "2023-02-16",
      "transaction_shares": "3235.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "205466.8049"
    },
    {
      "id": 131881,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-02-16",
      "transaction_shares": "1941.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "18119.0000"
    },
    {
      "id": 131942,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-16",
      "transaction_shares": "9671.0000",
      "transaction_price": "35.6767",
      "transaction_type": "M",
      "shares_after_transaction": "37151.0000"
    },
    {
      "id": 181729,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP & Grp President TAVR & SSH",
      "transaction_date": "2023-02-16",
      "transaction_shares": "3235.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "205466.8049"
    },
    {
      "id": 181750,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-02-16",
      "transaction_shares": "1941.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "18119.0000"
    },
    {
      "id": 181817,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-16",
      "transaction_shares": "9671.0000",
      "transaction_price": "35.6767",
      "transaction_type": "M",
      "shares_after_transaction": "37151.0000"
    },
    {
      "id": 52553,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-02-15",
      "transaction_shares": "96405.0000",
      "transaction_price": "0.0000",
      "transaction_type": "G",
      "shares_after_transaction": "60947.8200"
    },
    {
      "id": 52569,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-02-15",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 88390,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-02-15",
      "transaction_shares": "96405.0000",
      "transaction_price": "0.0000",
      "transaction_type": "G",
      "shares_after_transaction": "60947.8200"
    },
    {
      "id": 88413,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-02-15",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 131865,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-02-15",
      "transaction_shares": "96405.0000",
      "transaction_price": "0.0000",
      "transaction_type": "G",
      "shares_after_transaction": "60947.8200"
    },
    {
      "id": 131892,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-02-15",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 181731,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-02-15",
      "transaction_shares": "96405.0000",
      "transaction_price": "0.0000",
      "transaction_type": "G",
      "shares_after_transaction": "60947.8200"
    },
    {
      "id": 181762,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-02-15",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 52565,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-02-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 88408,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-02-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 131886,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-02-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 181756,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-02-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 52529,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-02-06",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 88355,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-02-06",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 131825,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-02-06",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 181689,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-02-06",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 27817,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-01-17",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 52552,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-01-17",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 88389,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-01-17",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 131864,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-01-17",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 181730,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-01-17",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 27853,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-01-13",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 52595,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-01-13",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 88450,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-01-13",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 131934,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-01-13",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 181809,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-01-13",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 27790,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-01-09",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 52519,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-01-09",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 88334,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-01-09",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 131799,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-01-09",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 181662,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-01-09",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 27794,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-12-15",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 52523,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-12-15",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 88344,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-12-15",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 131812,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-12-15",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 181676,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-12-15",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 27851,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-12-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 52593,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-12-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 88447,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-12-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 131930,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-12-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 181803,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-12-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 27795,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-12-13",
      "transaction_shares": "7236.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209467.8049"
    },
    {
      "id": 52524,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-12-13",
      "transaction_shares": "7236.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209467.8049"
    },
    {
      "id": 88348,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-12-13",
      "transaction_shares": "7236.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209467.8049"
    },
    {
      "id": 131817,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-12-13",
      "transaction_shares": "7236.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209467.8049"
    },
    {
      "id": 181681,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-12-13",
      "transaction_shares": "7236.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209467.8049"
    },
    {
      "id": 27856,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-12-12",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 52598,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-12-12",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 88454,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-12-12",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 131938,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-12-12",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 181813,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-12-12",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 27826,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-11-15",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 52563,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-11-15",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 88405,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-11-15",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 131882,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-11-15",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 181751,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-11-15",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 27860,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-11-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 52603,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-11-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 88460,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-11-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 131945,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-11-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 181820,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-11-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 27791,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-11-08",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 27797,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-11-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 52520,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-11-08",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 52527,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-11-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 88336,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-11-08",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 88352,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-11-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 131801,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-11-08",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 131822,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-11-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 181664,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-11-08",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 181686,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-11-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 11983,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-10-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 12004,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-10-14",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 27792,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-10-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 27816,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-10-14",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 52521,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-10-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 52550,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-10-14",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 88341,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-10-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 88387,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-10-14",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 131807,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-10-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 131862,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-10-14",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 181670,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-10-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 181728,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-10-14",
      "transaction_shares": "4000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22911.0000"
    },
    {
      "id": 11999,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-10-11",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 27811,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-10-11",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 52544,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-10-11",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 88376,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-10-11",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 131848,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-10-11",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 181713,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-10-11",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 12005,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-10-10",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 27818,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-10-10",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 52554,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-10-10",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 88392,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-10-10",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 131869,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-10-10",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 181735,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-10-10",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 11992,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-09-22",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 27804,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-09-22",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 52537,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-09-22",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 88369,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-09-22",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 131839,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-09-22",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 181704,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-09-22",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 12036,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-09-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 27850,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-09-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 52592,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-09-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 88446,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-09-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 131929,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-09-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 181802,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-09-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 12032,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-09-06",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 27846,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-09-06",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 52588,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-09-06",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 88440,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-09-06",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 131921,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-09-06",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 181793,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-09-06",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 11981,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-08-15",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 27788,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-08-15",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 52517,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-08-15",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 88332,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-08-15",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 131797,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-08-15",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 181660,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-08-15",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 11985,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-08-09",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 12020,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-08-09",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 27796,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-08-09",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 27834,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-08-09",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 52525,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-08-09",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 52575,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-08-09",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 88350,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-08-09",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 88422,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-08-09",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 131820,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-08-09",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 131901,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-08-09",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 181684,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-08-09",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 181773,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-08-09",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 11993,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-08-05",
      "transaction_shares": "4811.0000",
      "transaction_price": "103.6600",
      "transaction_type": "S",
      "shares_after_transaction": "21246.9647"
    },
    {
      "id": 27805,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-08-05",
      "transaction_shares": "4811.0000",
      "transaction_price": "103.6600",
      "transaction_type": "S",
      "shares_after_transaction": "21246.9647"
    },
    {
      "id": 52538,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-08-05",
      "transaction_shares": "4811.0000",
      "transaction_price": "103.6600",
      "transaction_type": "S",
      "shares_after_transaction": "21246.9647"
    },
    {
      "id": 88370,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-08-05",
      "transaction_shares": "4811.0000",
      "transaction_price": "103.6600",
      "transaction_type": "S",
      "shares_after_transaction": "21246.9647"
    },
    {
      "id": 131841,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-08-05",
      "transaction_shares": "4811.0000",
      "transaction_price": "103.6600",
      "transaction_type": "S",
      "shares_after_transaction": "21246.9647"
    },
    {
      "id": 181706,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-08-05",
      "transaction_shares": "4811.0000",
      "transaction_price": "103.6600",
      "transaction_type": "S",
      "shares_after_transaction": "21246.9647"
    },
    {
      "id": 11988,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-08-02",
      "transaction_shares": "1000.0000",
      "transaction_price": "102.4900",
      "transaction_type": "S",
      "shares_after_transaction": "18911.0000"
    },
    {
      "id": 27800,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-08-02",
      "transaction_shares": "1000.0000",
      "transaction_price": "102.4900",
      "transaction_type": "S",
      "shares_after_transaction": "18911.0000"
    },
    {
      "id": 52532,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-08-02",
      "transaction_shares": "1000.0000",
      "transaction_price": "102.4900",
      "transaction_type": "S",
      "shares_after_transaction": "18911.0000"
    },
    {
      "id": 88363,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-08-02",
      "transaction_shares": "1000.0000",
      "transaction_price": "102.4900",
      "transaction_type": "S",
      "shares_after_transaction": "18911.0000"
    },
    {
      "id": 131833,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-08-02",
      "transaction_shares": "1000.0000",
      "transaction_price": "102.4900",
      "transaction_type": "S",
      "shares_after_transaction": "18911.0000"
    },
    {
      "id": 181698,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-08-02",
      "transaction_shares": "1000.0000",
      "transaction_price": "102.4900",
      "transaction_type": "S",
      "shares_after_transaction": "18911.0000"
    },
    {
      "id": 2297,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-07-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 12019,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-07-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 27833,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-07-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 52574,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-07-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 88421,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-07-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 131900,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-07-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 181772,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-07-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 2279,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-07-08",
      "transaction_shares": "3675.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "103056.2782"
    },
    {
      "id": 2298,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-07-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 11998,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-07-08",
      "transaction_shares": "3675.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "103056.2782"
    },
    {
      "id": 12021,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-07-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 27810,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-07-08",
      "transaction_shares": "3675.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "103056.2782"
    },
    {
      "id": 27835,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-07-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 52543,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-07-08",
      "transaction_shares": "3675.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "103056.2782"
    },
    {
      "id": 52576,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-07-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 88375,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-07-08",
      "transaction_shares": "3675.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "103056.2782"
    },
    {
      "id": 88424,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-07-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 131846,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-07-08",
      "transaction_shares": "3675.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "103056.2782"
    },
    {
      "id": 131903,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-07-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 181711,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-07-08",
      "transaction_shares": "3675.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "103056.2782"
    },
    {
      "id": 181775,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-07-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 2303,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-07-07",
      "transaction_shares": "2032.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "35374.4980"
    },
    {
      "id": 2317,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-07-07",
      "transaction_shares": "6100.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "168874.8696"
    },
    {
      "id": 12026,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-07-07",
      "transaction_shares": "2032.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "35374.4980"
    },
    {
      "id": 12042,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-07-07",
      "transaction_shares": "6100.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "168874.8696"
    },
    {
      "id": 27840,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-07-07",
      "transaction_shares": "2032.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "35374.4980"
    },
    {
      "id": 27859,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-07-07",
      "transaction_shares": "6100.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "168874.8696"
    },
    {
      "id": 52581,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-07-07",
      "transaction_shares": "2032.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "35374.4980"
    },
    {
      "id": 52601,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-07-07",
      "transaction_shares": "6100.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "168874.8696"
    },
    {
      "id": 88431,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-07-07",
      "transaction_shares": "2032.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "35374.4980"
    },
    {
      "id": 88457,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-07-07",
      "transaction_shares": "6100.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "168874.8696"
    },
    {
      "id": 131911,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-07-07",
      "transaction_shares": "2032.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "35374.4980"
    },
    {
      "id": 131941,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-07-07",
      "transaction_shares": "6100.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "168874.8696"
    },
    {
      "id": 181783,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-07-07",
      "transaction_shares": "2032.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "35374.4980"
    },
    {
      "id": 181816,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-07-07",
      "transaction_shares": "6100.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "168874.8696"
    },
    {
      "id": 2290,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-07-05",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 12012,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-07-05",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 27825,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-07-05",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 52561,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-07-05",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 88402,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-07-05",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 131879,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-07-05",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 181748,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-07-05",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 2294,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-06-14",
      "transaction_shares": "4809.0000",
      "transaction_price": "87.7500",
      "transaction_type": "S",
      "shares_after_transaction": "26007.7011"
    },
    {
      "id": 2309,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-06-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 2313,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-06-14",
      "transaction_shares": "3675.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "103011.8018"
    },
    {
      "id": 12016,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-06-14",
      "transaction_shares": "4809.0000",
      "transaction_price": "87.7500",
      "transaction_type": "S",
      "shares_after_transaction": "26007.7011"
    },
    {
      "id": 12033,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-06-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 12038,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-06-14",
      "transaction_shares": "3675.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "103011.8018"
    },
    {
      "id": 27830,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-06-14",
      "transaction_shares": "4809.0000",
      "transaction_price": "87.7500",
      "transaction_type": "S",
      "shares_after_transaction": "26007.7011"
    },
    {
      "id": 27847,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-06-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 27854,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-06-14",
      "transaction_shares": "3675.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "103011.8018"
    },
    {
      "id": 52568,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-06-14",
      "transaction_shares": "4809.0000",
      "transaction_price": "87.7500",
      "transaction_type": "S",
      "shares_after_transaction": "26007.7011"
    },
    {
      "id": 52589,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-06-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 52596,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-06-14",
      "transaction_shares": "3675.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "103011.8018"
    },
    {
      "id": 88412,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-06-14",
      "transaction_shares": "4809.0000",
      "transaction_price": "87.7500",
      "transaction_type": "S",
      "shares_after_transaction": "26007.7011"
    },
    {
      "id": 88441,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-06-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 88452,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-06-14",
      "transaction_shares": "3675.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "103011.8018"
    },
    {
      "id": 131891,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-06-14",
      "transaction_shares": "4809.0000",
      "transaction_price": "87.7500",
      "transaction_type": "S",
      "shares_after_transaction": "26007.7011"
    },
    {
      "id": 131922,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-06-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 131936,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-06-14",
      "transaction_shares": "3675.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "103011.8018"
    },
    {
      "id": 181761,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-06-14",
      "transaction_shares": "4809.0000",
      "transaction_price": "87.7500",
      "transaction_type": "S",
      "shares_after_transaction": "26007.7011"
    },
    {
      "id": 181795,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-06-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 181811,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-06-14",
      "transaction_shares": "3675.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "103011.8018"
    },
    {
      "id": 2278,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-06-13",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 11997,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-06-13",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 27809,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-06-13",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 52542,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-06-13",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 88374,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-06-13",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 131845,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-06-13",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 181710,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-06-13",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 2296,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-06-01",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209441.0338"
    },
    {
      "id": 12018,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-06-01",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209441.0338"
    },
    {
      "id": 27832,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-06-01",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209441.0338"
    },
    {
      "id": 52572,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-06-01",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209441.0338"
    },
    {
      "id": 88418,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-06-01",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209441.0338"
    },
    {
      "id": 131897,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-06-01",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209441.0338"
    },
    {
      "id": 181769,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-06-01",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209441.0338"
    },
    {
      "id": 2288,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-31",
      "transaction_shares": "9000.0000",
      "transaction_price": "100.8321",
      "transaction_type": "S",
      "shares_after_transaction": "30816.0000"
    },
    {
      "id": 12010,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-31",
      "transaction_shares": "9000.0000",
      "transaction_price": "100.8321",
      "transaction_type": "S",
      "shares_after_transaction": "30816.0000"
    },
    {
      "id": 27823,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-31",
      "transaction_shares": "9000.0000",
      "transaction_price": "100.8321",
      "transaction_type": "S",
      "shares_after_transaction": "30816.0000"
    },
    {
      "id": 52559,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-31",
      "transaction_shares": "9000.0000",
      "transaction_price": "100.8321",
      "transaction_type": "S",
      "shares_after_transaction": "30816.0000"
    },
    {
      "id": 88400,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-31",
      "transaction_shares": "9000.0000",
      "transaction_price": "100.8321",
      "transaction_type": "S",
      "shares_after_transaction": "30816.0000"
    },
    {
      "id": 131877,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-31",
      "transaction_shares": "9000.0000",
      "transaction_price": "100.8321",
      "transaction_type": "S",
      "shares_after_transaction": "30816.0000"
    },
    {
      "id": 181746,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-31",
      "transaction_shares": "9000.0000",
      "transaction_price": "100.8321",
      "transaction_type": "S",
      "shares_after_transaction": "30816.0000"
    },
    {
      "id": 2301,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-26",
      "transaction_shares": "1000.0000",
      "transaction_price": "98.3118",
      "transaction_type": "S",
      "shares_after_transaction": "19911.0000"
    },
    {
      "id": 12024,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-26",
      "transaction_shares": "1000.0000",
      "transaction_price": "98.3118",
      "transaction_type": "S",
      "shares_after_transaction": "19911.0000"
    },
    {
      "id": 27838,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-26",
      "transaction_shares": "1000.0000",
      "transaction_price": "98.3118",
      "transaction_type": "S",
      "shares_after_transaction": "19911.0000"
    },
    {
      "id": 52579,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-26",
      "transaction_shares": "1000.0000",
      "transaction_price": "98.3118",
      "transaction_type": "S",
      "shares_after_transaction": "19911.0000"
    },
    {
      "id": 88428,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-26",
      "transaction_shares": "1000.0000",
      "transaction_price": "98.3118",
      "transaction_type": "S",
      "shares_after_transaction": "19911.0000"
    },
    {
      "id": 131907,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-26",
      "transaction_shares": "1000.0000",
      "transaction_price": "98.3118",
      "transaction_type": "S",
      "shares_after_transaction": "19911.0000"
    },
    {
      "id": 181779,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-26",
      "transaction_shares": "1000.0000",
      "transaction_price": "98.3118",
      "transaction_type": "S",
      "shares_after_transaction": "19911.0000"
    },
    {
      "id": 2268,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-24",
      "transaction_shares": "4809.0000",
      "transaction_price": "95.5200",
      "transaction_type": "S",
      "shares_after_transaction": "39816.0000"
    },
    {
      "id": 11982,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-24",
      "transaction_shares": "4809.0000",
      "transaction_price": "95.5200",
      "transaction_type": "S",
      "shares_after_transaction": "39816.0000"
    },
    {
      "id": 27789,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-24",
      "transaction_shares": "4809.0000",
      "transaction_price": "95.5200",
      "transaction_type": "S",
      "shares_after_transaction": "39816.0000"
    },
    {
      "id": 52518,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-24",
      "transaction_shares": "4809.0000",
      "transaction_price": "95.5200",
      "transaction_type": "S",
      "shares_after_transaction": "39816.0000"
    },
    {
      "id": 88333,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-24",
      "transaction_shares": "4809.0000",
      "transaction_price": "95.5200",
      "transaction_type": "S",
      "shares_after_transaction": "39816.0000"
    },
    {
      "id": 131798,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-24",
      "transaction_shares": "4809.0000",
      "transaction_price": "95.5200",
      "transaction_type": "S",
      "shares_after_transaction": "39816.0000"
    },
    {
      "id": 181661,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-24",
      "transaction_shares": "4809.0000",
      "transaction_price": "95.5200",
      "transaction_type": "S",
      "shares_after_transaction": "39816.0000"
    },
    {
      "id": 2274,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1953.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "29261.0000"
    },
    {
      "id": 2275,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1644.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "20911.0000"
    },
    {
      "id": 2283,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1816.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "204253.0338"
    },
    {
      "id": 2284,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1711.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "44625.0000"
    },
    {
      "id": 2291,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-17",
      "transaction_shares": "211.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "11436.4609"
    },
    {
      "id": 2292,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1743.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "62560.7842"
    },
    {
      "id": 2304,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-17",
      "transaction_shares": "963.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "99336.8018"
    },
    {
      "id": 2306,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1730.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "33303.6569"
    },
    {
      "id": 2314,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-17",
      "transaction_shares": "143.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "162756.3402"
    },
    {
      "id": 11991,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1953.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "29261.0000"
    },
    {
      "id": 11994,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1644.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "20911.0000"
    },
    {
      "id": 12003,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1816.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "204253.0338"
    },
    {
      "id": 12006,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1711.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "44625.0000"
    },
    {
      "id": 12013,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-17",
      "transaction_shares": "211.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "11436.4609"
    },
    {
      "id": 12014,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1743.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "62560.7842"
    },
    {
      "id": 12027,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-17",
      "transaction_shares": "963.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "99336.8018"
    },
    {
      "id": 12029,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1730.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "33303.6569"
    },
    {
      "id": 12039,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-17",
      "transaction_shares": "143.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "162756.3402"
    },
    {
      "id": 27803,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1953.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "29261.0000"
    },
    {
      "id": 27806,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1644.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "20911.0000"
    },
    {
      "id": 27815,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1816.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "204253.0338"
    },
    {
      "id": 27819,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1711.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "44625.0000"
    },
    {
      "id": 27827,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-17",
      "transaction_shares": "211.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "11436.4609"
    },
    {
      "id": 27828,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1743.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "62560.7842"
    },
    {
      "id": 27841,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-17",
      "transaction_shares": "963.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "99336.8018"
    },
    {
      "id": 27843,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1730.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "33303.6569"
    },
    {
      "id": 27855,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-17",
      "transaction_shares": "143.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "162756.3402"
    },
    {
      "id": 52536,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1953.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "29261.0000"
    },
    {
      "id": 52539,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1644.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "20911.0000"
    },
    {
      "id": 52549,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1816.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "204253.0338"
    },
    {
      "id": 52555,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1711.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "44625.0000"
    },
    {
      "id": 52564,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-17",
      "transaction_shares": "211.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "11436.4609"
    },
    {
      "id": 52566,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1743.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "62560.7842"
    },
    {
      "id": 52582,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-17",
      "transaction_shares": "963.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "99336.8018"
    },
    {
      "id": 52585,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1730.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "33303.6569"
    },
    {
      "id": 52597,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-17",
      "transaction_shares": "143.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "162756.3402"
    },
    {
      "id": 88368,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1953.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "29261.0000"
    },
    {
      "id": 88371,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1644.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "20911.0000"
    },
    {
      "id": 88386,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1816.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "204253.0338"
    },
    {
      "id": 88393,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1711.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "44625.0000"
    },
    {
      "id": 88406,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-17",
      "transaction_shares": "211.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "11436.4609"
    },
    {
      "id": 88409,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1743.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "62560.7842"
    },
    {
      "id": 88433,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-17",
      "transaction_shares": "963.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "99336.8018"
    },
    {
      "id": 88436,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1730.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "33303.6569"
    },
    {
      "id": 88453,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-17",
      "transaction_shares": "143.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "162756.3402"
    },
    {
      "id": 131838,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1953.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "29261.0000"
    },
    {
      "id": 131842,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1644.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "20911.0000"
    },
    {
      "id": 131861,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1816.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "204253.0338"
    },
    {
      "id": 131870,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1711.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "44625.0000"
    },
    {
      "id": 131883,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-17",
      "transaction_shares": "211.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "11436.4609"
    },
    {
      "id": 131887,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1743.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "62560.7842"
    },
    {
      "id": 131913,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-17",
      "transaction_shares": "963.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "99336.8018"
    },
    {
      "id": 131917,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1730.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "33303.6569"
    },
    {
      "id": 131937,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-17",
      "transaction_shares": "143.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "162756.3402"
    },
    {
      "id": 181703,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1953.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "29261.0000"
    },
    {
      "id": 181707,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1644.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "20911.0000"
    },
    {
      "id": 181726,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1816.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "204253.0338"
    },
    {
      "id": 181737,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1711.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "44625.0000"
    },
    {
      "id": 181753,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-17",
      "transaction_shares": "211.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "11436.4609"
    },
    {
      "id": 181757,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1743.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "62560.7842"
    },
    {
      "id": 181785,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-17",
      "transaction_shares": "963.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "99336.8018"
    },
    {
      "id": 181789,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1730.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "33303.6569"
    },
    {
      "id": 181812,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-17",
      "transaction_shares": "143.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "162756.3402"
    },
    {
      "id": 2276,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-05-08",
      "transaction_shares": "56831.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "157352.8200"
    },
    {
      "id": 11995,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-05-08",
      "transaction_shares": "56831.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "157352.8200"
    },
    {
      "id": 27807,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-05-08",
      "transaction_shares": "56831.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "157352.8200"
    },
    {
      "id": 52540,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-05-08",
      "transaction_shares": "56831.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "157352.8200"
    },
    {
      "id": 88372,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-05-08",
      "transaction_shares": "56831.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "157352.8200"
    },
    {
      "id": 131843,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-05-08",
      "transaction_shares": "56831.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "157352.8200"
    },
    {
      "id": 181708,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-05-08",
      "transaction_shares": "56831.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "157352.8200"
    },
    {
      "id": 2270,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-07",
      "transaction_shares": "595.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "30255.6569"
    },
    {
      "id": 2271,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-07",
      "transaction_shares": "363.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "97553.8018"
    },
    {
      "id": 2273,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-07",
      "transaction_shares": "51.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "154983.3402"
    },
    {
      "id": 2282,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-07",
      "transaction_shares": "679.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "200820.0338"
    },
    {
      "id": 2286,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2022-05-07",
      "transaction_shares": "772.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "25111.0000"
    },
    {
      "id": 2300,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-07",
      "transaction_shares": "305.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "18493.0000"
    },
    {
      "id": 2302,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-07",
      "transaction_shares": "604.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "59315.7842"
    },
    {
      "id": 2311,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-07",
      "transaction_shares": "134.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "11802.4609"
    },
    {
      "id": 2315,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-07",
      "transaction_shares": "633.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "40573.0000"
    },
    {
      "id": 11986,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-07",
      "transaction_shares": "595.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "30255.6569"
    },
    {
      "id": 11987,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-07",
      "transaction_shares": "363.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "97553.8018"
    },
    {
      "id": 11990,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-07",
      "transaction_shares": "51.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "154983.3402"
    },
    {
      "id": 12002,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-07",
      "transaction_shares": "679.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "200820.0338"
    },
    {
      "id": 12008,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2022-05-07",
      "transaction_shares": "772.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "25111.0000"
    },
    {
      "id": 12023,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-07",
      "transaction_shares": "305.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "18493.0000"
    },
    {
      "id": 12025,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-07",
      "transaction_shares": "604.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "59315.7842"
    },
    {
      "id": 12035,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-07",
      "transaction_shares": "134.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "11802.4609"
    },
    {
      "id": 12040,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-07",
      "transaction_shares": "633.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "40573.0000"
    },
    {
      "id": 27798,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-07",
      "transaction_shares": "595.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "30255.6569"
    },
    {
      "id": 27799,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-07",
      "transaction_shares": "363.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "97553.8018"
    },
    {
      "id": 27802,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-07",
      "transaction_shares": "51.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "154983.3402"
    },
    {
      "id": 27814,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-07",
      "transaction_shares": "679.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "200820.0338"
    },
    {
      "id": 27821,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2022-05-07",
      "transaction_shares": "772.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "25111.0000"
    },
    {
      "id": 27837,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-07",
      "transaction_shares": "305.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "18493.0000"
    },
    {
      "id": 27839,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-07",
      "transaction_shares": "604.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "59315.7842"
    },
    {
      "id": 27849,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-07",
      "transaction_shares": "134.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "11802.4609"
    },
    {
      "id": 27857,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-07",
      "transaction_shares": "633.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "40573.0000"
    },
    {
      "id": 52528,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-07",
      "transaction_shares": "595.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "30255.6569"
    },
    {
      "id": 52530,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-07",
      "transaction_shares": "363.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "97553.8018"
    },
    {
      "id": 52534,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-07",
      "transaction_shares": "51.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "154983.3402"
    },
    {
      "id": 52548,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-07",
      "transaction_shares": "679.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "200820.0338"
    },
    {
      "id": 52557,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2022-05-07",
      "transaction_shares": "772.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "25111.0000"
    },
    {
      "id": 52578,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-07",
      "transaction_shares": "305.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "18493.0000"
    },
    {
      "id": 52580,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-07",
      "transaction_shares": "604.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "59315.7842"
    },
    {
      "id": 52591,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-07",
      "transaction_shares": "134.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "11802.4609"
    },
    {
      "id": 52599,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-07",
      "transaction_shares": "633.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "40573.0000"
    },
    {
      "id": 88353,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-07",
      "transaction_shares": "595.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "30255.6569"
    },
    {
      "id": 88359,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-07",
      "transaction_shares": "363.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "97553.8018"
    },
    {
      "id": 88365,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-07",
      "transaction_shares": "51.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "154983.3402"
    },
    {
      "id": 88384,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-07",
      "transaction_shares": "679.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "200820.0338"
    },
    {
      "id": 88396,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2022-05-07",
      "transaction_shares": "772.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "25111.0000"
    },
    {
      "id": 88427,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-07",
      "transaction_shares": "305.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "18493.0000"
    },
    {
      "id": 88430,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-07",
      "transaction_shares": "604.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "59315.7842"
    },
    {
      "id": 88444,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-07",
      "transaction_shares": "134.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "11802.4609"
    },
    {
      "id": 88455,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-07",
      "transaction_shares": "633.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "40573.0000"
    },
    {
      "id": 131823,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-07",
      "transaction_shares": "595.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "30255.6569"
    },
    {
      "id": 131829,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-07",
      "transaction_shares": "363.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "97553.8018"
    },
    {
      "id": 131835,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-07",
      "transaction_shares": "51.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "154983.3402"
    },
    {
      "id": 131858,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-07",
      "transaction_shares": "679.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "200820.0338"
    },
    {
      "id": 131873,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2022-05-07",
      "transaction_shares": "772.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "25111.0000"
    },
    {
      "id": 131906,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-07",
      "transaction_shares": "305.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "18493.0000"
    },
    {
      "id": 131910,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-07",
      "transaction_shares": "604.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "59315.7842"
    },
    {
      "id": 131927,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-07",
      "transaction_shares": "134.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "11802.4609"
    },
    {
      "id": 131939,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-07",
      "transaction_shares": "633.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "40573.0000"
    },
    {
      "id": 181687,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-07",
      "transaction_shares": "595.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "30255.6569"
    },
    {
      "id": 181693,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-07",
      "transaction_shares": "363.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "97553.8018"
    },
    {
      "id": 181700,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-07",
      "transaction_shares": "51.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "154983.3402"
    },
    {
      "id": 181723,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-07",
      "transaction_shares": "679.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "200820.0338"
    },
    {
      "id": 181740,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2022-05-07",
      "transaction_shares": "772.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "25111.0000"
    },
    {
      "id": 181778,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-07",
      "transaction_shares": "305.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "18493.0000"
    },
    {
      "id": 181782,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-07",
      "transaction_shares": "604.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "59315.7842"
    },
    {
      "id": 181800,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-07",
      "transaction_shares": "134.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "11802.4609"
    },
    {
      "id": 181814,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-07",
      "transaction_shares": "633.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "40573.0000"
    },
    {
      "id": 2269,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "51880.0000"
    },
    {
      "id": 2272,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4915.0000"
    },
    {
      "id": 2281,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-04",
      "transaction_shares": "307.0000",
      "transaction_price": "105.9300",
      "transaction_type": "F",
      "shares_after_transaction": "97916.8018"
    },
    {
      "id": 2285,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "66111.0000"
    },
    {
      "id": 2287,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Marsh Martha H.",
      "reporting_owner_cik": "0001500281",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "29077.0000"
    },
    {
      "id": 2293,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4915.0000"
    },
    {
      "id": 2310,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2300.0000"
    },
    {
      "id": 2318,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "27480.0000"
    },
    {
      "id": 11984,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "51880.0000"
    },
    {
      "id": 11989,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4915.0000"
    },
    {
      "id": 12001,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-04",
      "transaction_shares": "307.0000",
      "transaction_price": "105.9300",
      "transaction_type": "F",
      "shares_after_transaction": "97916.8018"
    },
    {
      "id": 12007,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "66111.0000"
    },
    {
      "id": 12009,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Marsh Martha H.",
      "reporting_owner_cik": "0001500281",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "29077.0000"
    },
    {
      "id": 12015,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4915.0000"
    },
    {
      "id": 12034,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2300.0000"
    },
    {
      "id": 12043,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "27480.0000"
    },
    {
      "id": 27793,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "51880.0000"
    },
    {
      "id": 27801,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4915.0000"
    },
    {
      "id": 27813,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-04",
      "transaction_shares": "307.0000",
      "transaction_price": "105.9300",
      "transaction_type": "F",
      "shares_after_transaction": "97916.8018"
    },
    {
      "id": 27820,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "66111.0000"
    },
    {
      "id": 27822,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Marsh Martha H.",
      "reporting_owner_cik": "0001500281",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "29077.0000"
    },
    {
      "id": 27829,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4915.0000"
    },
    {
      "id": 27848,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2300.0000"
    },
    {
      "id": 27861,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "27480.0000"
    },
    {
      "id": 52522,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "51880.0000"
    },
    {
      "id": 52533,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4915.0000"
    },
    {
      "id": 52546,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-04",
      "transaction_shares": "307.0000",
      "transaction_price": "105.9300",
      "transaction_type": "F",
      "shares_after_transaction": "97916.8018"
    },
    {
      "id": 52556,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "66111.0000"
    },
    {
      "id": 52558,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Marsh Martha H.",
      "reporting_owner_cik": "0001500281",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "29077.0000"
    },
    {
      "id": 52567,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4915.0000"
    },
    {
      "id": 52590,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2300.0000"
    },
    {
      "id": 52604,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "27480.0000"
    },
    {
      "id": 88342,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "51880.0000"
    },
    {
      "id": 88364,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4915.0000"
    },
    {
      "id": 88380,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-04",
      "transaction_shares": "307.0000",
      "transaction_price": "105.9300",
      "transaction_type": "F",
      "shares_after_transaction": "97916.8018"
    },
    {
      "id": 88395,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "66111.0000"
    },
    {
      "id": 88397,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Marsh Martha H.",
      "reporting_owner_cik": "0001500281",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "29077.0000"
    },
    {
      "id": 88410,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4915.0000"
    },
    {
      "id": 88443,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2300.0000"
    },
    {
      "id": 88463,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "27480.0000"
    },
    {
      "id": 131808,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "51880.0000"
    },
    {
      "id": 131834,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4915.0000"
    },
    {
      "id": 131853,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-04",
      "transaction_shares": "307.0000",
      "transaction_price": "105.9300",
      "transaction_type": "F",
      "shares_after_transaction": "97916.8018"
    },
    {
      "id": 131872,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "66111.0000"
    },
    {
      "id": 131874,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Marsh Martha H.",
      "reporting_owner_cik": "0001500281",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "29077.0000"
    },
    {
      "id": 131888,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4915.0000"
    },
    {
      "id": 131925,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2300.0000"
    },
    {
      "id": 131948,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "27480.0000"
    },
    {
      "id": 181672,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "51880.0000"
    },
    {
      "id": 181699,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4915.0000"
    },
    {
      "id": 181718,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-04",
      "transaction_shares": "307.0000",
      "transaction_price": "105.9300",
      "transaction_type": "F",
      "shares_after_transaction": "97916.8018"
    },
    {
      "id": 181739,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "66111.0000"
    },
    {
      "id": 181742,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Marsh Martha H.",
      "reporting_owner_cik": "0001500281",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "29077.0000"
    },
    {
      "id": 181758,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4915.0000"
    },
    {
      "id": 181798,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2300.0000"
    },
    {
      "id": 181823,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "27480.0000"
    },
    {
      "id": 2267,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3775.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "60415.7842"
    },
    {
      "id": 2277,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3250.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "19077.0000"
    },
    {
      "id": 2280,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-05-03",
      "transaction_shares": "21250.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "100521.8200"
    },
    {
      "id": 2295,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-03",
      "transaction_shares": "4150.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "41576.0000"
    },
    {
      "id": 2305,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-03",
      "transaction_shares": "1180.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "12052.4609"
    },
    {
      "id": 2308,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-03",
      "transaction_shares": "4425.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "202066.0338"
    },
    {
      "id": 2312,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-03",
      "transaction_shares": "2750.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "155076.3402"
    },
    {
      "id": 2316,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3775.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31343.6569"
    },
    {
      "id": 11980,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3775.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "60415.7842"
    },
    {
      "id": 11996,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3250.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "19077.0000"
    },
    {
      "id": 12000,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-05-03",
      "transaction_shares": "21250.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "100521.8200"
    },
    {
      "id": 12017,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-03",
      "transaction_shares": "4150.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "41576.0000"
    },
    {
      "id": 12028,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-03",
      "transaction_shares": "1180.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "12052.4609"
    },
    {
      "id": 12031,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-03",
      "transaction_shares": "4425.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "202066.0338"
    },
    {
      "id": 12037,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-03",
      "transaction_shares": "2750.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "155076.3402"
    },
    {
      "id": 12041,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3775.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31343.6569"
    },
    {
      "id": 27787,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3775.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "60415.7842"
    },
    {
      "id": 27808,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3250.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "19077.0000"
    },
    {
      "id": 27812,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-05-03",
      "transaction_shares": "21250.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "100521.8200"
    },
    {
      "id": 27831,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-03",
      "transaction_shares": "4150.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "41576.0000"
    },
    {
      "id": 27842,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-03",
      "transaction_shares": "1180.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "12052.4609"
    },
    {
      "id": 27845,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-03",
      "transaction_shares": "4425.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "202066.0338"
    },
    {
      "id": 27852,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-03",
      "transaction_shares": "2750.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "155076.3402"
    },
    {
      "id": 27858,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3775.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31343.6569"
    },
    {
      "id": 52516,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3775.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "60415.7842"
    },
    {
      "id": 52541,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3250.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "19077.0000"
    },
    {
      "id": 52545,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-05-03",
      "transaction_shares": "21250.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "100521.8200"
    },
    {
      "id": 52570,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-03",
      "transaction_shares": "4150.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "41576.0000"
    },
    {
      "id": 52584,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-03",
      "transaction_shares": "1180.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "12052.4609"
    },
    {
      "id": 52587,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-03",
      "transaction_shares": "4425.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "202066.0338"
    },
    {
      "id": 52594,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-03",
      "transaction_shares": "2750.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "155076.3402"
    },
    {
      "id": 52600,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3775.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31343.6569"
    },
    {
      "id": 88327,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3775.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "60415.7842"
    },
    {
      "id": 88373,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3250.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "19077.0000"
    },
    {
      "id": 88379,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-05-03",
      "transaction_shares": "21250.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "100521.8200"
    },
    {
      "id": 88414,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-03",
      "transaction_shares": "4150.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "41576.0000"
    },
    {
      "id": 88435,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-03",
      "transaction_shares": "1180.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "12052.4609"
    },
    {
      "id": 88439,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-03",
      "transaction_shares": "4425.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "202066.0338"
    },
    {
      "id": 88448,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-03",
      "transaction_shares": "2750.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "155076.3402"
    },
    {
      "id": 88456,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3775.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31343.6569"
    },
    {
      "id": 131792,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3775.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "60415.7842"
    },
    {
      "id": 131844,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3250.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "19077.0000"
    },
    {
      "id": 131852,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-05-03",
      "transaction_shares": "21250.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "100521.8200"
    },
    {
      "id": 131893,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-03",
      "transaction_shares": "4150.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "41576.0000"
    },
    {
      "id": 131915,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-03",
      "transaction_shares": "1180.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "12052.4609"
    },
    {
      "id": 131920,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-03",
      "transaction_shares": "4425.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "202066.0338"
    },
    {
      "id": 131932,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-03",
      "transaction_shares": "2750.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "155076.3402"
    },
    {
      "id": 131940,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3775.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31343.6569"
    },
    {
      "id": 181655,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3775.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "60415.7842"
    },
    {
      "id": 181709,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3250.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "19077.0000"
    },
    {
      "id": 181717,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-05-03",
      "transaction_shares": "21250.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "100521.8200"
    },
    {
      "id": 181764,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-03",
      "transaction_shares": "4150.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "41576.0000"
    },
    {
      "id": 181787,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-03",
      "transaction_shares": "1180.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "12052.4609"
    },
    {
      "id": 181792,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-03",
      "transaction_shares": "4425.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "202066.0338"
    },
    {
      "id": 181807,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-03",
      "transaction_shares": "2750.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "155076.3402"
    },
    {
      "id": 181815,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3775.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31343.6569"
    },
    {
      "id": 2307,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-04-29",
      "transaction_shares": "45050.0000",
      "transaction_price": "21.7600",
      "transaction_type": "M",
      "shares_after_transaction": "124321.8200"
    },
    {
      "id": 12030,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-04-29",
      "transaction_shares": "45050.0000",
      "transaction_price": "21.7600",
      "transaction_type": "M",
      "shares_after_transaction": "124321.8200"
    },
    {
      "id": 27844,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-04-29",
      "transaction_shares": "45050.0000",
      "transaction_price": "21.7600",
      "transaction_type": "M",
      "shares_after_transaction": "124321.8200"
    },
    {
      "id": 52586,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-04-29",
      "transaction_shares": "45050.0000",
      "transaction_price": "21.7600",
      "transaction_type": "M",
      "shares_after_transaction": "124321.8200"
    },
    {
      "id": 88438,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-04-29",
      "transaction_shares": "45050.0000",
      "transaction_price": "21.7600",
      "transaction_type": "M",
      "shares_after_transaction": "124321.8200"
    },
    {
      "id": 131919,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-04-29",
      "transaction_shares": "45050.0000",
      "transaction_price": "21.7600",
      "transaction_type": "M",
      "shares_after_transaction": "124321.8200"
    },
    {
      "id": 181791,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-04-29",
      "transaction_shares": "45050.0000",
      "transaction_price": "21.7600",
      "transaction_type": "M",
      "shares_after_transaction": "124321.8200"
    },
    {
      "id": 2289,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Marsh Martha H.",
      "reporting_owner_cik": "0001500281",
      "reporting_owner_position": null,
      "transaction_date": "2022-04-28",
      "transaction_shares": "28722.0000",
      "transaction_price": "25.9883",
      "transaction_type": "M",
      "shares_after_transaction": "55499.0000"
    },
    {
      "id": 12011,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Marsh Martha H.",
      "reporting_owner_cik": "0001500281",
      "reporting_owner_position": null,
      "transaction_date": "2022-04-28",
      "transaction_shares": "28722.0000",
      "transaction_price": "25.9883",
      "transaction_type": "M",
      "shares_after_transaction": "55499.0000"
    },
    {
      "id": 27824,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Marsh Martha H.",
      "reporting_owner_cik": "0001500281",
      "reporting_owner_position": null,
      "transaction_date": "2022-04-28",
      "transaction_shares": "28722.0000",
      "transaction_price": "25.9883",
      "transaction_type": "M",
      "shares_after_transaction": "55499.0000"
    },
    {
      "id": 52560,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Marsh Martha H.",
      "reporting_owner_cik": "0001500281",
      "reporting_owner_position": null,
      "transaction_date": "2022-04-28",
      "transaction_shares": "28722.0000",
      "transaction_price": "25.9883",
      "transaction_type": "M",
      "shares_after_transaction": "55499.0000"
    },
    {
      "id": 88401,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Marsh Martha H.",
      "reporting_owner_cik": "0001500281",
      "reporting_owner_position": null,
      "transaction_date": "2022-04-28",
      "transaction_shares": "28722.0000",
      "transaction_price": "25.9883",
      "transaction_type": "M",
      "shares_after_transaction": "55499.0000"
    },
    {
      "id": 131878,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Marsh Martha H.",
      "reporting_owner_cik": "0001500281",
      "reporting_owner_position": null,
      "transaction_date": "2022-04-28",
      "transaction_shares": "28722.0000",
      "transaction_price": "25.9883",
      "transaction_type": "M",
      "shares_after_transaction": "55499.0000"
    },
    {
      "id": 181747,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Marsh Martha H.",
      "reporting_owner_cik": "0001500281",
      "reporting_owner_position": null,
      "transaction_date": "2022-04-28",
      "transaction_shares": "28722.0000",
      "transaction_price": "25.9883",
      "transaction_type": "M",
      "shares_after_transaction": "55499.0000"
    }
  ]
}